Simplex Trading
KALV

Simplex Trading’s KalVista Pharmaceuticals KALV Stock Holding History

Simplex Trading’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310K Buy
+15,400
New +$248K ﹤0.01% 3792
2025
Q4 		– Sell
-600
Closed -$7K – 9316
2025
Q3 		$7K Sell
600
-1,400
-70% -$19.3K ﹤0.01% 8112
2025
Q2 		$22K Buy
+2,000
New +$24.5K ﹤0.01% 6695
2025
Q1 		– Sell
-126,800
Closed -$1.07M – 9066
2024
Q4 		$1.07M Buy
126,800
+125,600
+10,467% +$1.3M ﹤0.01% 2762
2024
Q3 		$13K Sell
1,200
-4,300
-78% -$54.1K ﹤0.01% 7003
2024
Q2 		$64K Sell
5,500
-7,100
-56% -$82.9K ﹤0.01% 5820
2024
Q1 		$149K Sell
12,600
-400,200
-97% -$5.34M ﹤0.01% 5160
2023
Q4 		$5.06M Buy
412,800
+408,400
+9,282% +$3.72M ﹤0.01% 1541
2023
Q3 		$42K Buy
+4,400
New +$45K ﹤0.01% 5963
2021
Q4 		– Sell
-8,500
Closed -$208K – 10935
2021
Q3 		$208K Hold
8,500
– – ﹤0.01% 5534
2021
Q2 		$203K Buy
8,500
+8,454
+18,378% +$221K ﹤0.01% 5659
2021
Q1 		$118K Buy
46
+28
+156% +$736 ﹤0.01% 5508
2020
Q4 		$34K Buy
+18
New +$309 ﹤0.01% 6560

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Simplex Trading's KALV Position: Q3 2025 in Review

Simplex Trading sold out of KalVista Pharmaceuticals (KALV) in Q3 2025, closing a stake of 3,543 shares — an estimated $49K sold.

Simplex Trading first reported a position in KALV in Q4 2020 and held it in 14 quarters. The position peaked at $297K in Q4 2024. 145 funds tracked by Wall St. Rank hold KALV as of Q3 2025.

  • Simplex Trading reported no remaining KalVista Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 3,543 KalVista Pharmaceuticals shares in Q3 2025, an estimated $49K.
  • Simplex Trading first reported a position in KalVista Pharmaceuticals in Q4 2020 and held it in 14 quarters.
  • Simplex Trading's KalVista Pharmaceuticals position peaked at $297K in Q4 2024.
  • 145 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.